Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


Analysis of clinical trials does not show a significant association between depression and beta-interferon (IFNβ) treatment in multiple sclerosis (MS).

MS is considered as a considerable...

The US Food and Drug Administration (FDA) has given Q Therapeutics, developer of clinical-stage cell therapies for central system disease and injury, the go ahead on a...

The current focus for the treatment of multiple sclerosis (MS) is on early diagnosis and drug intervention, with a view to modifying disease progression. As a result, healthcare costs have shifted...

People with multiple sclerosis (MS) have high risk of osteoporosis and fractures. A poor vitamin D status is a risk factor for MS, and vitamin D supplementation has been recommended by healthcare...

A prospective cohort study of 192 patients from the southern Alberta MS clinic registry explored why and in what circumstance people with MS may experience depression. The study’s researchers...

According to a report, funded by Sanofi Genzyme and conducted by Adelphi Research UK, The UK has one of the lowest ...

The European Medicines Agency (EMA) has provisionally restricted the use of multiple sclerosis (MS) drug Zinbryta (daclizumab) to patients with highly active relapsing remitting MS (RRMS) that has...

New research has found that mothers who breastfeed for 15 months or more have a 53% lower risk of developing MS.

The study compared 397 women, who had recently been diagnosed with MS or...

A 54-year-old woman with multiple sclerosis (MS) has reportedly developed follicular lymphoma after eight months of therapy with Aubagio, also known as teriflunomide.

This is...

Pages

Live Chat Software by Click4Assistance UK